Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
about
Dietary, metabolic, and potentially environmental modulation of the lysine acetylation machineryInhaled corticosteroids for stable chronic obstructive pulmonary diseaseInhaled corticosteroids for stable chronic obstructive pulmonary diseaseRegulatory factor for X-box family proteins differentially interact with histone deacetylases to repress collagen alpha2(I) gene (COL1A2) expressionPDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilastEpigenetics and airways diseaseN-acetylcysteine in COPD: why, how, and when?Lung Regeneration: Endogenous and Exogenous Stem Cell Mediated Therapeutic ApproachesThe relationship between COPD and lung cancerSIRT1 as a therapeutic target in inflammaging of the pulmonary diseaseNuclear receptor coregulators: modulators of pathology and therapeutic targetsOxidative stress-induced autophagy: role in pulmonary toxicityBeyond the genome: epigenetic mechanisms in lung remodelingInterrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatmentsRepair and regeneration of the respiratory system: complexity, plasticity, and mechanisms of lung stem cell functionGenomic impact of cigarette smoke, with application to three smoking-related diseasesA critical role for dendritic cells in the evolution of IL-1β-mediated murine airway diseaseRole of macrophage migration inhibitory factor in age-related lung diseaseLow dose theophylline showed an inhibitory effect on the production of IL-6 and IL-8 in primary lung fibroblast from patients with COPDGene expression profile and toxic effects in human bronchial epithelial cells exposed to zearalenoneAnti-inflammatory and anti-remodelling effects of ISU201, a modified form of the extracellular domain of human BST2, in experimental models of asthma: association with inhibition of histone acetylationHistone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injuryLipopolysaccharide induces up-regulation of TGF-α through HDAC2 in a rat model of bronchopulmonary dysplasiaHyperoxia arrests alveolar development through suppression of histone deacetylases in neonatal ratsHop functions downstream of Nkx2.1 and GATA6 to mediate HDAC-dependent negative regulation of pulmonary gene expressionGlucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary diseaseOxidative Stress in COPD: Sources, Markers, and Potential MechanismsTargeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease.Long-term effects of acupuncture treatment on airway smooth muscle in a rat model of smoke-induced chronic obstructive pulmonary disease.Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function.Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review.Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.Comprehensive Analysis of Transcriptome Sequencing Data in the Lung Tissues of COPD Subjects.Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease.Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells.TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanismsSUV39H1 Reduction Is Implicated in Abnormal Inflammation in COPD.Protein kinase C zeta mediates cigarette smoke/aldehyde- and lipopolysaccharide-induced lung inflammation and histone modifications.Inhaled CorticosteroidsTheophylline.
P2860
Q21296850-020F6280-3177-49C6-AC5B-9B5E41F2E9FAQ24202092-FA650575-1FCB-4BD4-BA14-9DC6CC9DDF8BQ24245481-A0D4A7ED-EB70-4490-81AC-FAD49A437278Q24289242-13FA0010-4A57-49C3-BDAC-A2370A7CB6E0Q24646836-32C423E7-5654-4961-A685-1DCE06738408Q25256981-F7FB8903-55E6-4F74-B801-E90084068608Q26768289-780F1595-F553-417D-9E5F-0A552A2D4636Q26770098-FEF2ABEE-06DE-4D09-9236-689B834EE157Q26781337-DBD0968B-6272-4FA1-9FAE-3F07AB7697DBQ26829351-A257BAEB-6A72-41F3-86F8-9F106E2A8BB2Q26859163-BD778F36-2921-4A33-963A-04EDD50644E5Q26861392-F9C0FFCB-B7ED-40F3-8712-C0A1DCF723E7Q27021767-220DCDC0-10B7-4712-B852-96C5B4202909Q27023723-0A761468-497A-4067-BC82-71D307866FAEQ27023880-AA383FC3-5148-469F-82EE-34371520D30AQ27027763-DC5F3444-6EAA-45D6-A592-26BF2EC8E908Q27302341-85C01457-AE1B-4614-8989-35D740F3F352Q28081711-6FB7491C-3ED6-4F55-B117-44658CC0EC20Q28396352-F164CA36-ECC8-499D-A350-149790A6E660Q28538432-7057059C-B040-4A79-8FC2-051C6EBE11FDQ28540323-BCC5AF3E-573E-4DF5-9F31-121580241237Q28569252-4DBFFA7C-7D3C-4362-BE1E-07F76764AA50Q28578094-4F7C8A0B-78EE-43D8-892A-7A83A8922F19Q28579280-4DFD33B9-CB19-43F9-95DD-C8921F019E41Q28589392-F1650B52-3E5D-4CE0-B955-A32E13B4AB26Q28761895-B2E8A153-9A7E-4BF0-B49B-C0779A8F3686Q29247910-7B0860C2-3E7D-4993-B5B3-58AC27F744C1Q30372524-05C7F4E6-F408-4027-9E8B-2AD9981D08B4Q30378871-37729EEB-7EAC-43B6-9B43-BDBA873645BCQ30427183-4CEA9CDB-93D5-4A36-B73A-39D1EC94E47FQ30478617-850C484E-3827-46F4-A45E-8166E736DF01Q30884939-276615E0-394B-4729-9391-6D562AAFC1B7Q30922000-B83A1B15-77B2-4A3B-AEA2-8E1E832C9DDEQ33373335-964241EC-0F6F-4F00-8EB7-082A3578FCCCQ33426080-A23272E1-2A47-47D3-9B20-911924587F0EQ33486526-085A170A-947E-4C3C-BF5A-7C38E67E7758Q33582967-F7C70767-44CD-4892-B516-03D8DEC96520Q33648365-C1821A35-6DC3-47B8-AAAF-DA72F56C01FDQ33664193-3A2EB9BD-AE49-401E-9904-4751AC43C071Q33664235-3559C2B1-0F79-4438-B790-427497080559
P2860
Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
@en
Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
@nl
type
label
Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
@en
Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
@nl
prefLabel
Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
@en
Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
@nl
P2093
P356
P1476
Decreased histone deacetylase activity in chronic obstructive pulmonary disease.
@en
P2093
Adam Barczyk
Gaetano Caramori
James C Hogg
Kazuhiro Ito
Misako Ito
Onn Min Kon
Peter J Barnes
Shizu Hayashi
W Mark Elliott
P304
P356
10.1056/NEJMOA041892
P407
P577
2005-05-01T00:00:00Z